Clinical Trials /

Adolescent and Young Adult Survivor Transition

NCT02948712

Description:

The purpose of this study is to help adolescents and young adult cancer survivors address their psycho-social needs during the transitional period. The transitional period begins at completion of cancer treatment and continues throughout that first year. Patients often report this period can be difficult and distressing in many areas of life. This study will use a simple tool to measure, on a regular basis, the level of distress a young adult may be feeling. Based on this assessment additional mental health support and intervention can be recommended to help cancer survivors cope and enhance their feelings of well-being.

Related Conditions:
  • Cancer
Recruiting Status:

Suspended

Phase:

N/A

Trial Eligibility

Document

Title

  • Brief Title: Adolescent and Young Adult Survivor Transition
  • Official Title: Adolescent and Young Adult Survivor Transition (AYAST)

Clinical Trial IDs

  • ORG STUDY ID: CASE8Z16
  • NCT ID: NCT02948712

Conditions

  • Adolescent and Young Adult Cancer

Purpose

The purpose of this study is to help adolescents and young adult cancer survivors address their psycho-social needs during the transitional period. The transitional period begins at completion of cancer treatment and continues throughout that first year. Patients often report this period can be difficult and distressing in many areas of life. This study will use a simple tool to measure, on a regular basis, the level of distress a young adult may be feeling. Based on this assessment additional mental health support and intervention can be recommended to help cancer survivors cope and enhance their feelings of well-being.

Detailed Description

      Study Objective:

      To establish a successful distress based intervention program for adolescent and young adult
      survivors in the transition period.

      Study Design and Methods:

      The type of design for this study is a feasibility pilot study with repeated measure, within
      group quantitative design. There is no randomization for this study. The patient will be
      assessed; at baseline, upon completion of therapy, and at regular three month intervals for
      the first year, for a total of five assessments. After receiving a referral a member of the
      AYAST team will contact the patient and set up the initial visit.
    

Trial Arms

NameTypeDescriptionInterventions
Survivor DistressExperimentalThis intervention will use the NCCN Distress Screening Thermometer to score each participant on their level of distress. Depending on the score the intervention will be tailored to the participant based on the Overview of Evaluation and Treatment Schema DIS-4 per the NCCN Distress Guidelines V1.0, 2016.

    Eligibility Criteria

            Inclusion Criteria:
    
              -  Completed cancer treatment within the past three months of all cancer types and
                 stages
    
              -  Signed, written consent
    
            Exclusion Criteria:
    
              -  Have not completed cancer treatment within the past three months
          
    Maximum Eligible Age:30 Years
    Minimum Eligible Age:18 Years
    Eligible Gender:All
    Healthy Volunteers:No

    Primary Outcome Measures

    Measure:Decrease in distress score according to National Comprehensive Cancer Network (NCCN) Guidelines V 1.0.2016
    Time Frame:Up to 15 months after initial visit
    Safety Issue:
    Description:The study coordinators are using the NCCN Distress Screening Thermometer (DST) to screen patients. This includes a using the combined score of the NCCN DST and the associated problem list containing 39 items

    Details

    Phase:N/A
    Primary Purpose:Interventional
    Overall Status:Not yet recruiting
    Lead Sponsor:Case Comprehensive Cancer Center

    Trial Keywords

    • distress
    • survivorship
    • transition period

    Last Updated

    October 27, 2016